Inventor
Haiqing Yuan
Inventor
Irvine, CA, US
Overview
Patents· 37 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds31%
C07CAcyclic or carbocyclic compounds15%
A61KPreparations for medical, dental or toiletry purposes12%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium9%
PatentTitleYear
10,717,730Dihydroisoquinoline compound202010,647,712Dihydroisoquinoline compound202010,287,243Sulfur derivatives as chemokine receptor modulators201910,287,27516-member triamilide derivatives and uses thereof20199,670,190'Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators'20179,663,460'Sulfur derivatives as chemokine receptor modulators'20179,603,834'1,2- bis-sulfonamide derivatives as chemokine receptor modulators'20179,550,746'Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators'20179,416,120'Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators'20169,371,278'Sulfur derivatives as chemokine receptor modulators'20169,328,067'Sulfur derivatives as chemokine receptor modulators'20168,927,544'Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators'20158,877,804'Sulfur derivatives as chemokine receptor modulators'20148,822,530'Sulfur derivatives as chemokine receptor modulators'20148,815,915'Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators'20148,791,161'Sulfur derivatives as chemokine receptor modulators'20148,729,066'1,2- bis-sulfonamide derivatives as chemokine receptor modulators'20148,614,326'Therapeutic quinoline and naphthalene derivatives'20138,580,779'1,2-bis-sulfonamide derivatives as chemokine receptor modulators'20138,536,339'AZA-indoles and related compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity'20138,524,745'Benzisothiazol-3(1H)-one-5-sulfonyl derivatives as chemokine receptor modulators'20138,524,917'6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity'20138,518,913'Phosphorous derivatives as chemokine receptor modulators'20138,450,367'Sulfur derivatives as chemokine receptor modulators'20138,404,863'Tetrahydroindoles having sphingosine-1-phosphate receptor activity'20138,263,767'AZA-indoles and related compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity'20128,143,291'Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity'20128,097,644'Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist'20128,012,992'Aza-indoles and related compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity'20117,888,336'Indole compounds bearing aryl or heteroaryl groups having sphingosine 1-phosphate (S1P) receptor biological activity'20117,737,173'Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity'20107,728,014'Heteroaromatic compounds having sphingosine-1-phosphate (S1P) receptor agonist biological activity'20106,887,896'7-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activity'20056,884,820'5,6,7,8-tetrahydronaphthalen-2-yl-7-fluoroalkyl-heptatrienoic acid derivatives having serum glucose reducing activity'20056,864,282'9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma'20056,759,547'5,6,7,8-tetrahydronaphthalen-2-yl 2,6-difluoroheptatrienoic acid derivatives having serum glucose reducing activity'20046,759,546'3,5-di-iso-propyl-heptatrienoic acid derivatives having serum glucose reducing activity'2004Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2004–2019Patents assigned to ALLERGAN INC (34)· patent assignee history
2004–2019Based in Irvine, CA, US· patent location history
2012–2019Patents assigned to YUAN HAIQING (11)· patent assignee history
2012–2013Patents assigned to BEARD RICHARD L (7)· patent assignee history
2012–2013Patents assigned to DONELLO JOHN E (7)· patent assignee history
2013Patents assigned to GARST MICHAEL E (4)· patent assignee history
2020Based in Suzhou, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALLERGAN INC | 34 | 2004–2019 |
| YUAN HAIQINGself | 11 | 2012–2019 |
| BEARD RICHARD L | 7 | 2012–2013 |
| DONELLO JOHN E | 7 | 2012–2013 |
| GARST MICHAEL E | 4 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Irvine, California, US | 35 | 2004–2019 |
| Suzhou, CN | 2 | 2020 |